BG Growth Series – Boiron
Welcome to the “BG Growth Series”, where entrepreneurs tell us about their inspiring stories, share invaluable insights, and offer practical tips to navigate the growth journey.
Boiron is a century old pioneering company in homeopathy, dedicated to developing, manufacturing, and marketing homeopathic medicines. Since 1932, Boiron has been sharing its passion for homeopathy with a compassionate, ecological, and comprehensive approach to medicine. Boiron’s journey is a testament to resilience and a long history of unmatched quality and innovation.
We sat down with the President and Chairman of Boiron to understand his vision and commitment to innovation. His leadership highlights the company’s deep roots in homeopathy with his family founding Boiron over 90 years ago, continuing to drive forward with passion and dedication.
In their latest phase of growth, Boiron sought a partner to continue developing the group internationally and make it a global leader in natural health. Bryan Garnier was selected for their expertise in mergers & acquisitions, debt financing and equity capital markets to support the family shareholders, the management team and the BOIRON Group at every stage of this complex transaction. The team demonstrated an exceptional ability in understanding Boiron’s unique needs and helping to find the right partner to support U.S. expansion – EW Healthcare.
Boiron’s journey showcases a fundamental shift in how we perceive and deliver medicine, providing an alternative that many healthcare professionals and patients worldwide appreciate for its efficacy. With visionary leadership and unwavering dedication, Boiron is poised to continue transforming lives on a global scale with a holistic and ecological approach to medicine.
Watch this episode of BG Growth Series to learn more about Boiron leading the way in homeopathic medicine.
Get in touch
Whether you’re at the outset seeking funding, or an established firm searching for strategic options, our team will provide you with tailored advice to help you reach your goals.
Our transactions
Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European growth investment bank that helps healthcare and technology companies become global champions. By combining extensive sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and privileged access to buyers and capital in Europe, the US and Asia.
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan Garnier & Co is an independent partnership with around 200 employees located in major financial centres in Europe and the US.